chartexchange

Lucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive Year

PR Newswire | Nov 5, 2026 8:25 AM EST

NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has been named a GenomeWeb 2026 Best Places to...

Read original article